GrOwn Valve develops a prosthetic heart valve system that uses a patient’s own donated tissue combined with a bioresorbable anchoring device, delivered via a low‑risk transcatheter procedure. The autologous valve is designed to integrate permanently, providing lifelong durability and eliminating the need for repeat surgeries or lifelong medication for both adult and pediatric patients. The solution is offered as a complete procedure pack, targeting cardiac surgeons, interventional cardiology teams, and hospitals seeking a durable, minimally invasive, and cost‑effective valve replacement.
Funding
$8.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Congenital heart valve defects affect approximately 400,000 newborns each year, yet there is no durable, long‑lasting valve replacement that can be implanted minimally invasively, especially for children who outgrow conventional prostheses.
Solution
GrOwnValve is developing a prosthetic heart valve system that uses the patient’s own donated tissue combined with a bioresorbable anchoring device. The valve is delivered via a low‑risk transcatheter procedure, eliminating open‑heart surgery. Because the valve is made from endogenous tissue, it is intended to integrate permanently and provide lifelong durability, removing the need for repeated surgeries or lifelong medication. The product is offered as a complete procedure pack for both adult and pediatric patients, aiming to be affordable for healthcare systems worldwide.
Target Audience
Primary customers are cardiac surgeons and interventional cardiology teams treating congenital and acquired heart valve disease in pediatric and adult patients, as well as hospitals seeking durable, cost‑effective valve replacement options.
Features
- Autologous tissue‑based valve prosthesis that grows with the patient and avoids immune rejection
- Bioresorbable anchoring mechanism that dissolves after securing the valve, reducing long‑term foreign material
- Transcatheter delivery system enabling minimally invasive implantation for both adults and children
- Single‑procedure, lifelong solution designed to eliminate repeat valve replacement surgeries
- Procedure pack includes valve, anchoring device, and deployment tools for streamlined clinical use